Photopheresis and Human Immunodeficiency Virus (HIV) Infection: The Annals Views Preliminary Reports

  1. Elias Abrutyn, MD
  1. Associate Editor

    Excerpt

    This issue contains a preliminary report (1) describing a possible beneficial effect of extracorporeal photopheresis in patients with the acquired immunodeficiency syndrome (AIDS)-related complex. The justification for the experiment was the known inactivating effect of psoralens and long-wavelength ultraviolet A light on both DNA and RNA viruses, including human immunodeficiency virus (HIV) (2). In addition, photopheresis was found recently to be beneficial in the treatment of cutaneous T-cell lymphoma, a CD4 cell tumor (3).

    As described in the report by Bisaccia and colleagues (1), patients were given the photosensitizer, 8-methoxypsoralen, orally; 2 hours later, after absorption and distribution of the

    This 100-word excerpt has been provided in the absence of an abstract.

    | Table of Contents
    Most Read Most Read
    Most Commented Most Commented On
    Annals in the News Annals in the News
    Clinical Trials Clinical Trials
    Comparative Effectiveness Comparative Effectiveness
    Hospital Medicine Hospital Medicine
    • Advertisement
    • Advertisement